Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel F Tyndale

Showing results (71-80 of 359) with videos related to

Pageof 36
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smokingViba Malaiyandi, Shari D Goodz, Edward M Sellers, et al.
Molecular Pharmacology|December 19, 2002
Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African green monkeys after long-term nicotine administrationKerri A Schoedel, Edward M Sellers, Roberta Palmour, et al.
Pharmacogenetics and Genomics|February 9, 2017
Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African AmericansTaraneh Taghavi, Gideon St Helen, Neal L Benowitz, et al.
British Journal of Pharmacology|April 25, 2003
Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholicsLisa A Howard, Sharon Miksys, Ewa Hoffmann, et al.
Biological Psychiatry|November 21, 2016
CYP2A6 Genetic Variation Alters Striatal-Cingulate Circuits, Network Hubs, and Executive Processing in SmokersSufang Li, Yihong Yang, Ewa Hoffmann, et al.
Archives of Iranian Medicine|November 4, 2008
CYP2A6 allele frequencies in an Iranian populationMasoumeh Emamghoreishi, Hamid-Reza Bokaee, Mojtaba Keshavarz, et al.
Brain Research Bulletin|September 14, 2020
Centrally administered CYP2D inhibitors increase oral tramadol analgesia in ratsDouglas M McMillan, Ahmed A El-Sherbeni, Janielle Richards, et al.
Journal of Clinical Psychopharmacology|May 15, 2002
Designer drugs that are potent inhibitors of CYP2D6David Pritzker, Anish Kanungo, Tansel Kilicarslan, et al.
Respiratory Research|May 31, 2026
Faster CYP2A6 increases COPD and lung cancer risk by increasing smoking quantity: a mediated mendelian randomization and observational mediation studyHaidy Giratallah, Meghan J Chenoweth, Caryn Lerman, et al.
Neuropharmacology|August 9, 2008
Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatmentAmandeep Mann, Sharon Miksys, Anna Lee, et al.
Pageof 36

Showing results (71-80 of 359) with videos related to

Sort By:
Pageof 36
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smokingViba Malaiyandi, Shari D Goodz, Edward M Sellers, et al.
Molecular Pharmacology|December 19, 2002
Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African green monkeys after long-term nicotine administrationKerri A Schoedel, Edward M Sellers, Roberta Palmour, et al.
Pharmacogenetics and Genomics|February 9, 2017
Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African AmericansTaraneh Taghavi, Gideon St Helen, Neal L Benowitz, et al.
British Journal of Pharmacology|April 25, 2003
Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholicsLisa A Howard, Sharon Miksys, Ewa Hoffmann, et al.
Biological Psychiatry|November 21, 2016
CYP2A6 Genetic Variation Alters Striatal-Cingulate Circuits, Network Hubs, and Executive Processing in SmokersSufang Li, Yihong Yang, Ewa Hoffmann, et al.
Archives of Iranian Medicine|November 4, 2008
CYP2A6 allele frequencies in an Iranian populationMasoumeh Emamghoreishi, Hamid-Reza Bokaee, Mojtaba Keshavarz, et al.
Brain Research Bulletin|September 14, 2020
Centrally administered CYP2D inhibitors increase oral tramadol analgesia in ratsDouglas M McMillan, Ahmed A El-Sherbeni, Janielle Richards, et al.
Journal of Clinical Psychopharmacology|May 15, 2002
Designer drugs that are potent inhibitors of CYP2D6David Pritzker, Anish Kanungo, Tansel Kilicarslan, et al.
Respiratory Research|May 31, 2026
Faster CYP2A6 increases COPD and lung cancer risk by increasing smoking quantity: a mediated mendelian randomization and observational mediation studyHaidy Giratallah, Meghan J Chenoweth, Caryn Lerman, et al.
Neuropharmacology|August 9, 2008
Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatmentAmandeep Mann, Sharon Miksys, Anna Lee, et al.
Pageof 36